Riskpilot← Back to searchSign inGet full accessRyggbenke AB
ABIn liquidationOrg 5565883948FalunRetail sale of medical and orthopaedic goods · NACE 4774Est. 20000 employees
Revenue 2024
SEK 0
EBITDA margin
—
+6% vs 2023
Equity ratio
-556.1%
Financial strength
Net profit 2024
SEK -3K
+8% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -3K | +6% |
| Net profit | SEK -3K | +8% |
| Total assets | SEK 3K | +26% |
| Equity | SEK -14K | -27% |
| Employees | 0 | — |
Legal name
Ryggbenke AB
Org number
5565883948
Legal form
Aktiebolag
NACE code
4774 · Retail sale of medical and orthopaedic goods
Founded
10 april 2000
Share capital
SEK 200 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-06-30
Financial year
January – December
Signatory rights
Firman tecknas var för sig av likvidatorn externa firmatecknarna
Company purpose
Bolaget skall bedriva försäljning av sjukvårdsprodukter samt därmed förenlig verksamhet.
Address
Falun
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | −0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −4 | −4 | −6 | −3 | −3 |
| Depreciation & amort. | −4 | −4 | −1 | — | — |
| EBIT | −8 | −8 | −7 | −3 | −3 |
| Net financials | — | −1 | — | 0 | 0 |
| Profit before tax | −8 | −9 | −7 | −3 | −3 |
| Tax | −0 | −0 | — | — | — |
| Net profit | −8 | −9 | −7 | −3 | −3 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 7 | 2 | 1 | 2 | 3 |
| Equity | −490 | −499 | −8 | −11 | −14 |
| Long-term debt | 497 | 502 | 5 | 10 | 13 |
| Short-term debt | 0 | 1 | 4 | 3 | 3 |
| Total debt | 497 | 503 | 9 | 13 | 17 |
EBITDA margin
-299900.0%
This company
15.8%
Market median
-1898201% vs market
20202024
Equity ratio
-556.1%
This company
38.2%
Market median
-1556% vs market
20202024
Return on equity
-295100.0%
This company
18.4%
Market median
-1603904% vs market
20202024
Net profit margin
-295100.0%
This company
8.1%
Market median
-3643310% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
1.18×
This company
0.62×
Market median
-90% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-07-01 – 2020-06-30
| Name | Role | Member since |
|---|---|---|
| Current (5) | ||
LB External Signatory | External Signatory | 2025 |
IM External Signatory | External Signatory | 2025 |
BJ External Signatory | External Signatory | 2025 |
KO Liquidator | Liquidator | 2025 |
UM External Signatory | External Signatory | 2025 |
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
| Board of Directors | 2022 – 2025 | |
| Deputy Board Member | 2022 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Ryggbenke AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lena Birgitta Killgren Jonsson | External Signatory | 0 companies |
| Inger Margareta Dahle | External Signatory | 0 companies |
| Bengt Junior Niklas Nygårds | External Signatory | 0 companies |
| Knut Olof Mikael Rosén | Liquidator | 0 companies |
| Ulrika Margareta Ahlholm | External Signatory | 0 companies |
| Bengt Sune Johansson | Board of Directors | 0 companies |
| Ola Per Agnar Eckerdal | Deputy Board Member | 0 companies |